Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

15-4591 - Guidry v. Janssen Pharmaceuticals, Inc. et al


Download Files

Metadata

Document in Context
15-4591 - Guidry v. Janssen Pharmaceuticals, Inc. et al
February 17, 2016
PDF | More
ORDER & REASONS granting 11 & 13 Motions to Dismiss for Failure to State a Claim. Party Janssen Research & Development LLC, Johnson & Johnson Company, Johnson & Johnson Services, Inc., Mitsubishi Tanabe Pharma Corporation, Mitsubishi Tanabe Pharma Development America, Inc., Janssen Ortho, LLC and Janssen Pharmaceuticals, Inc. dismissed. If the plaintiff, in good faith, believes that she can allege facts to cure the defects of her LPLA claims, she must seek leave to amend her complaint within fourteen days. Signed by Judge Martin L.C. Feldman on 2/17/2016. (caa)
August 29, 2016
PDF | More
ORDER AND REASONS: ORDERED that the Mitsubishi Defendants'42 Motion to Dismiss for Failure to State a Claim is GRANTED. FURTHER ORDERED that the Janssen Defendants' 46 Motion to Dismiss for Failure to State a Claim is GRANTED IN PART and DENIED IN PART. Signed by Judge Martin L.C. Feldman on 8/29/16. (clc)